
Opinion|Videos|July 15, 2024
Similarities and Differences Among PSMA-PET Tracers
Author(s)Tony Abraham, DO, MPA
A nuclear radiologist provides an overview of the gallium- and fluorine-based PSMA-PET tracer options, highlighting factors that influence tracer selection.
Advertisement
Video Player is loading.
Episodes in this series

Video content above is prompted by the following questions:
- There are currently gallium- and fluorine-based PSMA-PET tracer options that are FDA approved. Can you review some of similarities and differences between the gallium and fluorine imaging tracer options identified above in terms of image quality and resolution? And accuracy and false positives?
- Gallium and fluorine tracers also have different half-lives. What does this mean in real-world practice in terms of patient scheduling and preparing for imaging? Can you provide any real-world examples of when one tracer may be preferential over another?
- There are two available F18 tracers available: 18F-Piflufolastat and 18F-Flotufolastat. What are some of the key differences between these? Can you share any examples of differences you’ve seen between these two tracers when used in real-world practice?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Christof Vulsteke, MD, PhD, breaks down findings, implications of KEYNOTE-905
2
The UroOnc Minute: Active Surveillance for Intermediate-risk Prostate Cancer, with Michael Leapman, MD, MHS
3
Petros Grivas, MD, on the significance of a perioperative regimen for cisplatin-ineligible MIBC
4
The Significance of KEYNOTE-905 in Muscle-Invasive Bladder Cancer
5






















